Antibody-mediated thrombosis.
Vermylen
J
J
Center for Molecular and Vascular Biology, University of Leuven, Belgium. jozef.vermylen@med.kuleuven.ac.be
Hoylaerts
M F
MF
Arnout
J
J
D000906:Antibodies / Q000097:blood*; D017152:Antibodies, Antiphospholipid / Q000276:immunology; D001323:Autoantibodies / Q000276:immunology; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000276:immunology; D013921:Thrombocytopenia / Q000139:chemically induced / Q000276:immunology*; D013927:Thrombosis / Q000139:chemically induced / Q000276:immunology*; D014841:von Willebrand Factor / Q000276:immunology
D000906:Antibodies; D017152:Antibodies, Antiphospholipid; D001323:Autoantibodies; D016682:Lupus Coagulation Inhibitor; D014841:von Willebrand Factor; D006493:Heparin